CN113403332A - Alpha-agarase gene and application of coding enzyme thereof - Google Patents

Alpha-agarase gene and application of coding enzyme thereof Download PDF

Info

Publication number
CN113403332A
CN113403332A CN202110650939.2A CN202110650939A CN113403332A CN 113403332 A CN113403332 A CN 113403332A CN 202110650939 A CN202110650939 A CN 202110650939A CN 113403332 A CN113403332 A CN 113403332A
Authority
CN
China
Prior art keywords
alpha
agarase
recombinant
bacillus subtilis
enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110650939.2A
Other languages
Chinese (zh)
Other versions
CN113403332B (en
Inventor
李兆丰
尤钰娴
班宵逢
李才明
顾正彪
程力
洪雁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN202110650939.2A priority Critical patent/CN113403332B/en
Publication of CN113403332A publication Critical patent/CN113403332A/en
Application granted granted Critical
Publication of CN113403332B publication Critical patent/CN113403332B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/14Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01158Alpha-agarase (3.2.1.158)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses an alpha-agarase gene and application of a coding enzyme thereof, belonging to the technical field of microbial engineering. The invention provides alpha-agarase with a specific base sequence, and successfully adopts a food safe strain bacillus subtilis to carry out heterologous expression on the alpha-agarase, the method is safe and efficient, and can be applied to the production of food and medicines, and the catalytic activity of the expressed alpha-agarase crude enzyme liquid can reach 523.1U/mg by adopting the method. The alpha-agarase provided by the invention has better specific enzyme activity and thermal stability, and the substrate conversion rate is higher; the conversion rate and the product purity of the alpha-agarase are high, the conversion rate can reach about 53 percent through calculation, and the alpha-agarase is beneficial to industrial production.

Description

Alpha-agarase gene and application of coding enzyme thereof
Technical Field
The invention relates to an alpha-agarase gene and application of a coding enzyme thereof, belonging to the technical field of genetic engineering and enzyme engineering.
Background
Agar is a marine polysaccharide of economic value which is extracted from gelidium and other red algae. The hydrolyzed agar generates agar oligosaccharide with the polymerization degree of 2-20, has the advantages of good water solubility, high bioavailability and the like, and can be widely applied to the fields of food, medicines, cosmetics and the like.
The agar oligosaccharide has a plurality of unique medical health care functions, can be used as a raw material of functional foods, medicines and cosmetics, and is mainly expressed as follows: 1) the agar oligosaccharide has antioxidant effect, and can remove active oxygen free radicals directly or by improving activity of antioxidant enzymes, and also has oxidation inhibiting effect by chelating agar oligosaccharide with metal ions essential for free radicals. Therefore, the product can be applied to health-care food with the functions of resisting fatigue and the like. 2) The agar oligosaccharide can inhibit the generation of nitric oxide in macrophage and monocyte, and the content of prostaglandin E2 and the increase of cell active substance level of proinflammatory reaction, and has the functions of resisting tumor and improving immunity. Can be used in the production of anti-tumor, anti-inflammatory and antiviral medicines. 3) Researches find that the agar oligosaccharide has good moisturizing and whitening effects, can inhibit the activity of tyrosinase in melanoma cells, and has no toxicity to the cells. Therefore, it can be used as a high-quality raw material for cosmetics. 4) The agar oligosaccharide has certain antibacterial activity, and can inhibit bacterial growth. The agar oligosaccharide can be used as natural antiseptic in food, and can reduce food calorie. 5) In vivo and in vitro experiments prove that the new agaro-oligosaccharide can tolerate the action of digestive enzyme, improve the intestinal flora structure, promote the proliferation of bifidobacteria and lactobacilli in the intestinal tract and inhibit the growth of pathogenic bacteria. The antibacterial effect of the agar oligosaccharide with high polymerization degree is better than that of the agar oligosaccharide with low polymerization degree. Therefore, the agar oligosaccharide can be used as a raw material for developing a novel prebiotics preparation.
In recent years, the development scale of agar in China is small, products are mostly limited to agar and agar powder which are used as raw material outlets of chemical engineering, medicines and the like, the added value is low, and the environment is easily polluted. The method has important significance for reasonably utilizing agar resources, producing high-added-value products such as agar oligosaccharide and the like, preventing resource waste, increasing economic benefits, protecting the environment and the like. At present, two modes of acid hydrolysis and enzymolysis are mainly used for preparing agar oligosaccharides industrially, the acid hydrolysis method has high efficiency and high yield, but a large amount of byproducts are generated, and the problems of difficult separation and purification, potential safety hazard and the like of the agar oligosaccharides exist; the agarase enzymolysis method has the advantages of high catalytic efficiency, strong substrate specificity, mild reaction conditions and the like, and is a preferred mode for degrading agar polysaccharide. However, most of researches for degrading agar polysaccharide by using an enzymatic method are still in the laboratory research stage, and the main problems are that most of strains for producing agarase come from the sea, the enzyme production characters of the strains are unstable, the enzyme production amount is low, the cost for producing the agarase is high, the price is high, and the commercial application is difficult to realize. Therefore, an agarase gene with high hydrolytic activity and stable properties is found, and heterologous expression is realized to become the most economical and efficient method for producing the agarase.
Agarase is divided into alpha-agarase and beta-agarase, wherein the alpha-agarase hydrolyzes alpha-1, 3 glycosidic bonds to generate agaro-oligosaccharides, and the beta-agarase hydrolyzes beta-1, 4 glycosidic bonds to generate new agaro-oligosaccharides. Researches report that agarotetraose and agarohexaose have better antioxidant performance compared with other agaropectides, but because most of agarases discovered at present are beta-agarases, only the performances of four alpha-agarases are mined and reported, and the stability, the enzyme activity and the product specificity of the agarases are all to be improved, the large-scale industrial preparation and application of the agarotetraose and the agarohexaose are severely limited.
Researchers at home and abroad try to perform heterologous expression on agarase so as to greatly improve the yield of the agarase and break through the secretion limit of natural enzyme, while the existing research mainly focuses on the cloning expression of the agarase in escherichia coli, is mainly positioned in cytoplasm or periplasm space, and is not beneficial to the separation and purification of the agarase and the application of the agarase in the fields of food, medicine and the like. Even if the agarase is secreted and expressed in bacillus subtilis, the secretion amount is relatively low, so that a safer and more efficient agarase food-grade bacillus subtilis secretion expression system needs to be established and optimized.
Disclosure of Invention
In order to solve the problems of rare sources, low expression quantity, low product conversion rate, poor specificity and the like of alpha-agarase in the prior art, the invention provides a gene for coding the alpha-agarase, and the nucleotide sequence of the alpha-agarase is shown as SEQ ID No. 1.
In one embodiment of the invention, the gene of the alpha-agarase is obtained by optimization based on the alpha-agarase WT with the nucleotide sequence shown in SEQ ID NO. 2.
The invention also provides a recombinant vector carrying the gene of the alpha-agarase.
The invention also provides a gene carrying the alpha-agarase or a recombinant cell of the recombinant vector.
The invention also provides a recombinant bacillus subtilis which contains the gene or the recombinant vector.
In one embodiment of the invention, the recombinant Bacillus subtilis takes Bacillus subtilis WB600, Bacillus subtilis WB800 or Bacillus subtilis 168 as an expression host.
In one embodiment of the present invention, the recombinant Bacillus subtilis uses pHT01 plasmid, pHT43 plasmid or pHT304 plasmid as expression vector.
The invention also provides a method for preparing the agar tetrasaccharide or the agar hexasaccharide, which comprises the following steps: the recombinant cells or the recombinant bacillus subtilis are fermented to prepare alpha-agarase, and agarose solution is hydrolyzed by the alpha-agarase to obtain the agar tetrasaccharide or the agar hexasaccharide.
In one embodiment of the present invention, the method is: inoculating the recombinant cells or recombinant bacillus subtilis into a seed culture medium to prepare a seed solution, and inoculating the seed solution into a fermentation culture medium for fermentation.
In one embodiment of the invention, the seed solution is inoculated into a fermentation medium according to the proportion of 2-4% (v/v), the culture is carried out for 60-72 h at 37 ℃, and the fermentation liquor is centrifuged to obtain the supernatant, thus obtaining the alpha-agarase crude enzyme solution.
In one embodiment of the invention, the agarose solution with 0.25-2% (w/w) of hydrolysis is prepared by using alpha-agarase crude enzyme liquid obtained by fermentation or pure enzyme obtained by nickel column purification at 30-40 ℃ to prepare the agarose or the agarose.
The invention also provides the application of the gene, the recombinant vector, the recombinant cell, the recombinant bacillus subtilis or the method in preparing a product containing setron tetraose or setron hexaose.
Advantageous effects
(1) The invention provides alpha-agarase with a specific base sequence, and successfully adopts a food safe strain bacillus subtilis to carry out heterologous expression on the alpha-agarase, the method is safe and efficient, and can be applied to the production of food and medicines, and the catalytic activity of the expressed alpha-agarase crude enzyme liquid can reach 523.1U/mg by adopting the method.
(2) The alpha-agarase provided by the invention has better specific enzyme activity and thermal stability, and the substrate conversion rate is higher.
(3) The conversion rate and the product purity of the alpha-agarase are high, the conversion rate can reach about 53 percent through calculation, the yield of the agar tetrasaccharide reaches 0.34g/g, the yield of the agar hexasaccharide reaches 0.19g/g, the yield of the rare agar oligosaccharide can be effectively improved, the production and processing cost of the agar oligosaccharide is reduced, and therefore the alpha-agarase has industrial application value.
Drawings
FIG. 1: SDS-PAGE analysis of purified recombinant α -agarase, in lane 1: crude enzyme solution; lane 2: purified alpha-AgaWT(ii) a Lane 3: purified alpha-Aga.
FIG. 2: relative enzyme activity data of alpha-agarase under different pH conditions.
FIG. 3: stability of the recombinant alpha-agarase under different pH conditions.
FIG. 4: performing HPLC (high performance liquid chromatography) atlas on a product obtained by hydrolyzing 0.25% (w/w) agarose solution by using the recombinant alpha-agarase alpha-Aga at different time; wherein, (A)1 h; (B)4 h; (C)12 h; (D) and (5) 24 h.
FIG. 5: performing HPLC (high performance liquid chromatography) atlas on a product obtained by hydrolyzing 0.5% (w/w) agarose solution by using the recombinant alpha-agarase alpha-Aga at different time; wherein, (A)1 h; (B)4 h; (C)12 h; (D) and (5) 24 h.
Detailed Description
The media involved in the following examples are as follows:
LB liquid medium: 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v) sodium chloride, pH 7.0.
LB solid medium: 1.5(w/v) agar was added to the LB liquid medium.
TB liquid medium: 1.2% (w/v) tryptone, 2.4% (w/v) yeast extract, 0.4% (w/v) glycerol, 17mM KH2PO4,72mM K2HPO4,pH 6.0。
The detection methods referred to in the following examples are as follows:
the method for measuring the enzyme activity of the recombinant alpha-agarase comprises the following steps: Tris-HCl buffer (20mM, pH 7.0) is used to prepare 3g/L agarose substrate, 0.1mL enzyme solution diluted properly is added into 0.9mL substrate, reaction is carried out for 60min at 60 ℃, 1mL 3, 5-dinitrosalicylic acid (DNS) solution is added to stop enzymatic reaction, cooling is carried out on ice bath after boiling water bath is carried out for 5min, and the absorbance value is measured at 540nm and is compared with glucose standard curve.
Definition of enzyme activity: the amount of enzyme required to produce 1. mu. mol of reducing sugar (in terms of glucose) per minute was 1 enzyme activity unit (U).
The detection method of the agar tetrasaccharide or the agar hexasaccharide comprises the following steps: and (3) carrying out boiling water bath on the agarose solution hydrolyzed by the recombinant alpha-agarase for 30min to inactivate the enzyme, centrifuging (10,000 Xg, 10min), diluting, passing through a 0.22 mu m water system filter membrane, and analyzing the product by using High Performance Liquid Chromatography (HPLC). The HPLC conditions were as follows: sugar Pak I column (Waters, MA, USA), with a column temperature of 75 deg.C and a mobile phase of 50mg/L EDTA-CaNa2The flow rate was 0.5 mL/min.
Example 1: construction of recombinant Bacillus subtilis secretion expression system
The method comprises the following specific steps:
(1) alpha-agarase alpha-Aga with the chemical synthesis nucleotide sequence shown as SEQ ID NO.1 and alpha-agarase with the chemical synthesis nucleotide sequence shown as SEQ ID NO.2WTα-AgaWT(i.e., alpha-agarase prior to optimization);
the PCR amplification procedure involved therein was: pre-denaturation at 98 deg.C for 3min, denaturation at 98 deg.C for 30s, annealing at 60 deg.C for 30s, extension at 68 deg.C for 2min, cyclic amplification for 35 times, and final extension at 68 deg.C for 5 min.
(2) And (2) respectively connecting the alpha-agarase genes obtained in the step (1) with pHT01 plasmid vectors by using a homologous recombination method. The connecting system is as follows: 1. mu.L of purified agarase PCR fragment (50 ng/. mu.L), 2. mu.L of purified pHT01 plasmid vector PCR fragment (50 ng/. mu.L), 4. mu.L of 5 XCE II Buffer, 2. mu.L of Exnase II, ddH2O11. mu.L. The homologous recombination conditions are as follows: incubating at 37 ℃ for 30 min; then, Escherichia coli E.coli JM109 is transformed, an LB solid culture medium with 5 mu g/mL kanamycin is coated, transformants are selected for sequencing and double enzyme digestion verification, and an expression vector containing alpha-agarase genes is obtained; transforming the expression vector into B.subtilis WB600 to obtain the genetic engineering bacteria B.subtilis WB600/pHT 01-alpha-Aga and B.subtilis WB600/pHT 01-alpha-AgaWT
Example 2: expression, separation and purification of recombinant alpha-agarase
The method comprises the following specific steps:
(1) respectively inoculating the single colony prepared in the example 1 into 50mL LB liquid culture medium containing 5 mug/mL kanamycin and 5 mug/mL gibberellin, and performing shake-flask culture at 37 ℃ and 200rpm for 8-12 h to prepare seed liquid;
respectively transferring the seed liquid obtained by the preparation to 50mL of TB liquid culture medium containing 5 mug/mL kanamycin and 5 mug/mL gibberellin according to the inoculum concentration of 4% (v/v), and performing shake-flask culture at 30 ℃ and 200rpm for 60-72 h to prepare fermentation liquid;
respectively taking 30mL of fermentation liquor with OD600 of 6.0, centrifuging at 4 ℃ and 10000rpm for 10min, taking supernatant, namely extracellular crude enzyme liquid, wherein the specific enzyme activity of the alpha-Aga crude enzyme liquid is as follows: 523.1U/mg; alpha-AgaWTThe specific enzyme activity of the crude enzyme solution is as follows: 360.4U/mg.
It can be seen that the enzyme activity of the crude enzyme solution of the original enzyme is lower than that of the specific sequence provided by the invention.
(2) Adopting a nickel column to carry out the step (1) on the prepared recombinant alpha-agarase alpha-Aga and alpha-AgaWTPurification was carried out with 500mM NaCl +50mM Tris-HCl +20mM imidazole in the equilibration solution (solution A, pH 7.5) and 500mM NaCl +50mM Tris-HCl +500mM imidazole in the eluent (solution B, pH 7.5). After cell sap is crushed and centrifuged, the pH of the supernatant is adjusted to 7.5, and the supernatant is filtered by a 0.45 mu m water system membrane to be purified. Balancing the ion column by using a buffer solution A with 5-6 column volumes at the flow rate of 2 mL/min; loading the sample at the flow rate of 2 mL/min; and then balancing the ion column by using 6-8 column volumes of buffer solution A, and then performing gradient elution by using 15% of buffer solution B at the flow rate of 2 mL/min. Collecting corresponding eluate according to the elution peak, placing in a dialysis bag, dialyzing overnight at 4 deg.C with 50mM Tris-HCl, pH 7.5, and then identifying by SDS-PAGE protein electrophoresis (the result is shown in FIG. 1) and enzyme activity determination. The calculated molecular weight of the recombinant alpha-agarase was reported to be 158.88kDa, consistent with the molecular weight estimated by SDS-PAGE.
Example 3: optimum pH and pH stability of recombinant alpha-agarase
The most suitable pH and pH stability of the purified recombinant alpha-agarase alpha-Aga prepared in the embodiment 2 are respectively detected, and the specific steps are as follows:
(1) the method for measuring the optimal pH of the recombinant alpha-agarase comprises the following steps: respectively adopting 50mM sodium citrate buffer solution (pH 3.0-6.0), Tris-HCl buffer solution (pH 6.0-8.0) and glycine-NaOH buffer solution (pH 8.0-11.0) to prepare substrate solutions, measuring the enzyme activity of the recombinase under different pH conditions, and taking the highest enzyme activity as 100%, wherein the results are shown in Table 1 and figure 2.
Table 1: relative enzyme activity data under different pH conditions
Figure BDA0003108818470000051
(2) The method for measuring the pH stability of the recombinant alpha-agarase comprises the following steps: respectively adopting 50mM sodium citrate buffer solution (pH 3.0-6.0), Tris-HCl buffer solution (pH 6.0-8.0) and glycine-NaOH buffer solution (pH 8.0-11.0) to prepare substrate solution and diluted enzyme solution, standing at 4 ℃ for 6h, measuring the residual enzyme activity, and taking the enzyme activity of the enzyme solution without heat preservation as 100%, wherein the results are shown in Table 2 and figure 3.
Table 2: relative enzyme activity data after standing for 6h under different pH conditions
Figure BDA0003108818470000052
The optimal pH and pH stability of the recombinant α -agarase are shown in fig. 3. The enzyme shows the highest activity in Gly-NaOH buffer solution with the pH of 8.0, has the strongest stability at the pH of 6.0, keeps the relative activity of more than 60 percent in the range of pH 7.0-10.0, and has better pH stability.
Example 4: application of recombinant alpha-agarase
Due to the original enzyme alpha-AgaWTThe enzyme activity of the alpha-Aga enzyme is far lower than that of the optimized alpha-Aga enzyme, so that the optimized alpha-Aga enzyme is adopted for the production and preparation of the agar oligosaccharide in the embodiment; the method comprises the following specific steps:
(1) 100g of agarose solutions were prepared at concentrations of 0.25% (w/w) and 0.5% (w/w), respectively.
(2) Placing agarose solutions with the concentrations of 0.25% (w/w) and 0.5% (w/w) in a water bath shaker at 40 ℃ for preheating for 10min to respectively obtain a reaction system 1 and a reaction system 2, and then respectively adding the pure enzyme solution prepared in the example 2 into the reaction systems 1 and 2; the addition amount is 10U/g, the reaction is carried out for 1-24 h in a water bath shaker at 40 ℃, and then the reaction is transferred to boiling water for inactivating enzyme for 20min to stop the reaction;
in this case, the enzyme solution was replaced with an equal amount of Tris-HCl buffer as a blank.
(3) After enzyme deactivation, centrifuging the reaction systems 1 and 2 for 10min at 10000rpm, respectively, taking supernate, passing through a water system membrane of 0.22 mu m to remove impurities, and analyzing the type and concentration of the agar oligosaccharide product in the reaction solution by using high performance liquid chromatography. The results are shown in Table 3:
table 3: the kind and concentration of the product under different substrate concentrations
Figure BDA0003108818470000061
As shown in fig. 4 (the yield of 0.25% of the substrate concentration of both the setron tetrose and the setron hexose) and fig. 5 (the yield of the substrate concentration of both the setron tetrose and the setron hexose), the main hydrolysis products are setron tetrose (a4) and setron hexose (a6), and the ratio of the setron tetrose is high; the total conversion can reach about 31% when the substrate concentration is 0.25%, and the total conversion can reach about 53% when the substrate concentration is 0.5%.
Comparative example 1:
the specific implementation manner is the same as that in examples 1-2, except that host bacteria are adjusted to be bacillus subtilis WB800 and BS168, and the results show that the specific enzyme activities of the prepared optimized recombinase alpha-agarase alpha-Aga crude enzyme solution are only respectively as follows: 216.8U/mg and 93.5U/mg.
Comparative example 2:
the specific implementation manner is the same as that in examples 1-2, except that the expression vectors are adjusted to pHT43 plasmid and pHT304 plasmid, and the results show that the specific activities of the prepared optimized recombinant enzyme alpha-agarase alpha-Aga crude enzyme solution are only respectively as follows: 130.2U/mg and 174.9U/mg.
Although the present invention has been described with reference to the preferred embodiments, it should be understood that various changes and modifications can be made therein by those skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.
SEQUENCE LISTING
<110> university of south of the Yangtze river
<120> application of alpha-agarase gene and coding enzyme thereof
<130> BAA200990A
<160> 2
<170> PatentIn version 3.3
<210> 1
<211> 4347
<212> DNA
<213> Artificial sequence
<400> 1
gaaacactgg ttctgcaagc agaatcattt gcaaattcag gcggcacata ttcagatggc 60
caaccgaatc cggttacaat ttataatgtt aacggccaag gcgcgattaa tttcgttaat 120
gcgggcgatt atgtggacta caatattaac gcactgggcg gcgaatatga tattgaatat 180
tttgtgggca caagcgtgtc aagcggcccg aatattgaag ttctggttaa tgttaatggc 240
acgtggcaat cacaaggctc agttgcagtt ccgtatggct catgggatga ttttcaatca 300
ctgacaccgt cacatacagt ttcactgccg gttggcacat caacagttag actgctggca 360
gttggctcaa catggcaatg gaatctggaa tcatttcgcc tgacacaggt ttcaagcgtt 420
gaaccggttg gcgatgcaga taatgatggc gtttatgata atcaggacct gtgcccgaat 480
acgccgtcag gcgttacagt tgataataat ggctgccaaa ttaacggcgg cacagatccg 540
gttggcgaat catttgttat tcaaatggaa gcatttgaca gcacgggctc agatgattca 600
agagcacaag gcgttgttat tggcgaaaga ggctatccgc aagataaaca tacagttgtt 660
gatagcgttc agacgacgga ctgggttgat tacagcatca actttccgtc atcaggcaat 720
tattcaatca gcatgctggc aagcggccaa acatcacatg caacagcagt tctgtttatt 780
gacggcacag aaattaatga ggtgccggtt catacaggca atcaagcaga ttttgaagac 840
tttcagctga cgtcaagcgt ttacgtggcg gcaggcacac atacagttag agttcaagca 900
caatcaagca caggcgaatt ttcatggctg tggtttggcg atacactgac atttacaaat 960
ctggacggcg atgatggctc agatggcggc aatggctcac cgacacaaga tgcagataat 1020
gatggcgttc tggattcatc agattcatgc ccgaatacac cgattggcga accggcagat 1080
gttacaggct gctcagcatc acaactggat gatgataatg atggcgtttc aaataacgtg 1140
gaccagtgcc cgaatacggt tgcaggcaca gaagttggcg cagatggctg cgaagttatt 1200
attgataatg acacggacaa cgacggcgtg ctgaataatg ttgatcaatg cccgaatacg 1260
ccgccgggcg caacagttga ttcaaatggc tgcgaagtta catttgcgga tacagataat 1320
gacggcattg aggattcaca agacttttgc ccgaatacgc cggcaggcga agcagttaat 1380
aattcaggct gcggcgaatc acaactggat gcagataatg atggcgttac aaataatatc 1440
gaccagtgcc cgaatacgcc ggcgggcaca caagttgatg catcaggctg cgaaattgat 1500
aatggcggcg aaccgggcga ttcatattat cataatggcc aaggcctgct gtttggcaga 1560
gttgatggcg caacaaattt tgttggcgaa gaaggctatg ttgcgaatcc ggataattat 1620
gacgttacga cggatctgct ggaaacagat gatgatatta gaggcaatag cacggaagtg 1680
tttcgcggcg aaatttatga tgcagatggc catatttcat tctacgagca tatcgacgac 1740
agcgtgagac tgtatatcga tggccaactg gttctgtcaa atgattcatg ggaaaatagc 1800
agccagacgc cggatctgtc actgacaccg ggatggcata attttgaact gagactgggc 1860
aatgcagatg gcggctcagg cgcagtttca ggcattggct ttggcattga tgttgatggc 1920
ggcacaaatt ttgttcaccc gtcaaatctg tcaccgtcaa tgtttagatc aagcggccaa 1980
gttgttgttg atccgattct gccgccgccg ggcggcattt atattcaact ggaagatttt 2040
gacgagacgg gcacagttgg cagagttgca tcagatccga atgatggctt tgttaaaggc 2100
gattcaaatg tgggctgggt tacaaatggc gattggggca aatatcataa tgtgttcctg 2160
gaggcaggca catacagagc atttattaca gtttcaacgc cggcaggcgg ctcatatggc 2220
gcaagagttg atattgatgg cgaaccgttt gcatggggct attttgattc aacaggcggc 2280
tgggatattg cagcagaata tgaactgtat ggcggcgatc tggttgttga atcaacaggc 2340
aatcatacac tgcatattga ggcggttggc ggctcagatt ggcaatggtc aggcgatctg 2400
gttagactgg caaaagttaa tgatagcacg gtgaagcagc cgagagttta caatccgaat 2460
gaacacctgg ttgcagaaat tgaaggcccg gcaacaggcc tgcaatatct gaaaacaccg 2520
gttgaaattc cgctggcaaa taaagttctg aaaagcgacg tttggtacac gtatccgcag 2580
aacagaaatc tggttgttga tggcgataca ccgtatgcag attttggcgc aacaggcgca 2640
ttttggggcc atccgcctga acatgatttt tatgatgata cggttatcat ggactgggca 2700
gttaatgttg tggatgactt tcaatcagag ggcttcgaat acacagcaag aggcgaattt 2760
gattggggct atggctggtt tacagaattt acaacaaatc cgcaaccgca ctatgttcaa 2820
acactggatg gcagaaatgt gagaatgaca tttatgggct atctgagcca tgatggctat 2880
aataataatt ggctgagcaa ccacagcccg gcatttgttc cgtttatgaa atcacaagtt 2940
gaccagatcc tgaaggcgaa cccggataaa ctgatgtttg acacgcagac aaatagcacg 3000
agaagcacag atatgagaga ttttggcggc gatttttcac cgtatgcaat ggaaaatttt 3060
cgcgtgtggc tgtcaaagaa gtattcatat gcagaactga gcgcgatggg cattaatgat 3120
attacaacat ttgactacaa gcagcacctg ctggatgcag gcgttacaca tacatcatgg 3180
tcaaatgcag gcgatagact ggaaggcaat attccgatgc tggaagattt tatttacttc 3240
aaccgcgacg tgtggaacca gaaattcgcg gaagtgctgg attatatcag acaacaaaga 3300
ccgaatattg agatcggcgc atcaacacat ctgtttgaat caagaggcta tgtgttcaac 3360
gagaacatta cattcctgag cggcgagctg aatctgggcg caagaacatc aatttcagaa 3420
ctgccgacaa atatcctggt gcatctgaaa ggcgcacaag cagttgataa aacactggca 3480
tattttccgt atccgtggga atttgatgaa ctgagactgc aaaatgcgcc gagatttggc 3540
agaggctggg ttgcacaagc atatgcatat ggcggcctgt tttcaattcc ggcaaatgtt 3600
tgggttggcg gcgaagtttt tacatggtca ccgggcgcag ataattatag agatatttat 3660
cagttcgtgc gcgcacaggc gaacctgttt gatggctata catcatatgc aaaggcgggc 3720
tatgttcacg cgatgttttc atcaatgaaa gcgggcttta ttgacggcgg caatcaagtt 3780
caatcatcag ttaaaattct gacggaggac aacatcaact ttgacatgct ggtgtttggc 3840
gacgcgggct atccggttgt tccgagacaa gcagattttg ataaattcga gcacatcttc 3900
tacgacggcg atctgaatta tctgacaacg gaacaaaaag cggttctgga tgcacaaggc 3960
tcaaaagtta gacatattgg ccaaagaggc tcactggcag gcctgcaaat taatgtttca 4020
attaatggct cagtgagcaa cgagacagtt agcgcagttt caagaattca cgaaacagac 4080
agcacggcgc cgtatgttgt tcatctgatt aatagaccgt ttgcgggcgg cgttacaccg 4140
attctgaata atgttgaagt tgcgatcccg gcgtcatatt tcccggaagg cgttacatca 4200
gcaaaactgc atctgccgga tggcacatca tcaacagttg cagtttcaac aaatgcgaac 4260
ggcgatgcag ttgtttcagt ttcaaatctg gaagtgtggg gcattctgga actggcacat 4320
ctcgagcacc accaccacca ccactga 4347
<210> 2
<211> 4323
<212> DNA
<213> Artificial sequence
<400> 2
gagacactag tgttacaagc agaatcgttt gccaactcag gcggcacata tagtgatggg 60
caaccaaacc ctgtcactat ttataatgta aacggtcaag gcgcgattaa tttcgttaat 120
gctggcgact atgttgatta caatatcaat gccctggggg gggaatacga tattgaatat 180
tttgttggga ccagtgtttc atctggaccc aatatagaag tgcttgttaa tgtaaatggt 240
acatggcaaa gtcaaggctc ggttgctgtt ccttatggta gctgggatga ctttcaatca 300
ctcacgccat ctcatacagt gtcattacca gtgggtactt cgactgttcg cttgttggcg 360
gtaggctcaa cttggcaatg gaacttagaa tcatttaggt taactcaagt ttcatccgtt 420
gaacctgttg gtgatgcaga taatgacggc gtctatgata atcaagattt atgccctaat 480
accccatcag gtgtcacagt tgacaataat ggttgtcaaa ttaatggagg cacagatccg 540
gttggagaat cctttgtcat ccagatggaa gcttttgatt caactggtag tgatgattca 600
agagcacaag gtgtggttat tggtgagcgt ggctacccac aagacaagca tacggttgtt 660
gatagtgtcc aaactactga ttgggtggat tatagtatta atttcccatc ttctggcaac 720
tacagcatat ctatgttggc atcagggcaa acctcgcatg caaccgccgt attatttatt 780
gatggcactg aaattaatga agtaccagtt catacaggta atcaagccga ttttgaagat 840
tttcaactaa ctagttctgt atatgttgca gctggcaccc atactgtacg agttcaggcg 900
caaagctcta ctggcgagtt tagttggtta tggtttggtg atacattaac tttcactaac 960
ttagacggtg acgatggtag tgatgggggc aatggctcgc ctacacaaga tgcggataac 1020
gatggtgtgt tggatagctc agattcttgt ccaaatacgc ctataggtga acctgcagat 1080
gtgactggct gtagtgcatc gcaattagat gatgacaatg atggtgtttc aaataatgtc 1140
gatcaatgtc ctaatacagt tgctggtaca gaggtaggcg ctgatggctg tgaagttatt 1200
attgataacg acacagataa tgatggtgtt ttaaataatg tcgaccagtg cccaaatacg 1260
ccaccaggcg caactgtaga ctcaaatgga tgtgaagtaa catttgctga tacagataat 1320
gacggcatag aagattcgca agatttttgc ccgaacacac cagcaggtga agcggtcaat 1380
aattcaggtt gtggtgagtc gcaattagat gccgataatg atggcgttac aaacaatata 1440
gaccaatgtc caaatacacc agcgggtaca caagttgatg cgtcaggttg tgagatcgac 1500
aatggtggtg agccaggtga tagttattat cacaatggtc aaggtttatt gtttggtcgt 1560
gtagatggcg caactaactt tgtaggtgaa gaaggctatg ttgccaaccc tgataactat 1620
gatgtgacaa ccgatttact cgagaccgat gatgacatta gaggaaactc tactgaagta 1680
ttccgtggtg agatttatga cgcagatggt catatttctt tctatgaaca tatagatgat 1740
agcgttcgtc tatatatcga cggtcaactc gtgctttcaa atgatagctg ggaaaactcg 1800
tctcaaactc cagatttaag cctcacacct ggttggcata attttgagtt aagacttggt 1860
aacgccgacg gtggcagtgg tgctgtgagt ggcatcggtt ttggtataga tgttgacggt 1920
ggcacaaact ttgttcaccc aagtaattta agccctagta tgtttagatc gagcggccaa 1980
gttgtggttg atccaatttt accaccacca ggcggaattt atattcagct agaagacttt 2040
gacgaaacag gtactgttgg ccgagtcgcg agcgatccaa acgatggctt tgttaaaggt 2100
gattcaaacg ttggttgggt taccaatgga gattggggta aataccacaa tgtattttta 2160
gaagctggta catatagagc attcattact gtatcaacac ctgcgggtgg tagttatggt 2220
gcacgtgttg atatagacgg cgaacctttt gcttggggat attttgatag cacaggtggc 2280
tgggatatcg cagcagaata tgagttgtat ggtggtgatt tagtcgtaga aagcactggt 2340
aaccatacgc tgcatattga agctgttggt gggtcagatt ggcagtggag tggcgactta 2400
gtgcgtttag ctaaagtgaa cgacagtaca gtcaaacaac ctcgtgtcta caatccaaac 2460
gaacatcttg ttgctgaaat cgaagggcct gcaactggtt tacaatattt aaaaacacca 2520
gtggaaattc cattagccaa taaggtatta aaatctgacg tttggtatac ctacccgcaa 2580
aaccgaaacc tagtcgttga cggtgacaca ccatacgctg actttggcgc aacgggtgcc 2640
ttctggggac atccacctga acacgatttc tacgatgata ctgtgatcat ggattgggcg 2700
gttaatgtcg ttgatgattt ccaaagtgaa gggtttgaat atactgcacg cggtgaattc 2760
gactggggtt atggctggtt tactgagttt acgactaatc cgcagccaca ttatgttcaa 2820
accttggatg gccgtaatgt acgtatgaca ttcatgggct atttaagcca tgacggttat 2880
aacaacaatt ggttaagtaa tcacagccca gcgtttgtac ctttcatgaa gtcacaggtt 2940
gatcaaatct taaaagcgaa cccggataag ttgatgtttg atacacaaac taactcaaca 3000
cgttcaactg atatgcgtga ctttggtggg gatttctctc cttatgcgat ggaaaatttc 3060
cgagtttggt tgtcgaagaa atacagctat gcagaactaa gcgctatggg tattaacgat 3120
attactacct ttgactataa gcagcactta ctggatgcag gtgtaactca tacatcatgg 3180
tcaaatgcag gagatagact cgaaggcaat attccaatgc ttgaagattt tatctacttt 3240
aatcgtgacg tttggaacca aaaatttgct gaagtattag attacattcg ccagcaaaga 3300
cctaatattg aaatcggtgc cagtacacac ctatttgaat cacgtggcta tgtatttaat 3360
gagaatatta ccttcttatc gggagagctt aatttaggtg caagaaccag tatttcagaa 3420
ttaccaacta atattcttgt acacttaaaa ggtgcgcaag cagttgataa aaccttggct 3480
tacttcccat atccgtggga gtttgatgaa ttacgtctac aaaatgcgcc tagatttggt 3540
cgtggttggg ttgctcaagc ttatgcttat ggtggcttat tctctattcc tgctaatgtg 3600
tgggtaggtg gtgaagtatt tacttggtca cctggtgctg ataactatcg cgatatctat 3660
caatttgtcc gtgcacaagc taacttattc gatggttata cctcatacgc gaaagctggt 3720
tatgttcacg ctatgttctc atcaatgaaa gctggtttta ttgatggtgg caaccaagtt 3780
caatcaagcg tgaaaatttt aactgaagat aatatcaatt ttgacatgtt agtgtttggt 3840
gatgcgggat atcctgttgt accacgccag gctgattttg ataaatttga gcatattttc 3900
tacgacggtg atctaaacta cttaacgact gagcaaaaag cagtattgga tgcacaaggt 3960
agtaaggttc gtcacattgg tcaacgcggt tctttagctg gtttacagat taatgtaagc 4020
attaatggta gtgtatctaa cgaaactgtg tctgctgtat ctcgtattca tgaaacagac 4080
tcaacggcac cttatgtagt acacctgatt aatcgtccgt ttgcgggtgg ggtaacacca 4140
atactgaaca atgttgaagt ggcaattcct gcaagctatt ttcctgaagg agtaacctca 4200
gcgaaattac acttaccaga tggaacaagt tcaaccgtcg cggtttcgac caatgcgaat 4260
ggcgatgctg ttgtatctgt tagtaatctt gaagtttggg gtattttaga attagctcac 4320
tga 4323

Claims (10)

1. A gene for coding alpha-agarase is characterized in that a nucleotide sequence for coding the alpha-agarase is shown as SEQ ID No. 1.
2. A recombinant vector carrying the gene of claim 1.
3. A recombinant cell carrying the gene of claim 1, or the recombinant vector of claim 2.
4. A recombinant Bacillus subtilis comprising the gene of claim 1 or the recombinant vector of claim 2.
5. The recombinant Bacillus subtilis according to claim 4 wherein Bacillus subtilis WB600, Bacillus subtilis WB800 or Bacillus subtilis 168 is the expression host.
6. The recombinant Bacillus subtilis of claim 4 or 5 wherein the expression vector is pHT01 plasmid, pHT43 plasmid or pHT304 plasmid.
7. A method for preparing setron tetrasaccharide or setron hexasaccharide is characterized by comprising the following steps: preparing the setron tetraose or the setron hexaose by fermenting the recombinant cell of claim 3 or the recombinant bacillus subtilis of any one of claims 4 to 6.
8. The method according to claim 7, wherein the recombinant cells or recombinant Bacillus subtilis are inoculated into a seed medium to prepare a seed solution, and the seed solution is inoculated into a fermentation medium to perform fermentation.
9. The method of claim 8, wherein the seed solution is inoculated into a fermentation medium according to the proportion of 2-4%, the seed solution is cultured for 60-72 hours at 37 ℃, and the fermentation liquid is centrifuged to take the supernatant, namely the fermentation liquid is fermented to prepare the agarotetraose or the agarohexaose.
10. Use of the gene of claim 1, or the recombinant vector of claim 2, or the recombinant cell of claim 3, or the recombinant bacillus subtilis of any one of claims 4 to 6, or the method of any one of claims 7 to 9 for the preparation of a product comprising setron tetraose or setron hexaose.
CN202110650939.2A 2021-06-09 2021-06-09 Alpha-agarase gene and application of coding enzyme thereof Active CN113403332B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110650939.2A CN113403332B (en) 2021-06-09 2021-06-09 Alpha-agarase gene and application of coding enzyme thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110650939.2A CN113403332B (en) 2021-06-09 2021-06-09 Alpha-agarase gene and application of coding enzyme thereof

Publications (2)

Publication Number Publication Date
CN113403332A true CN113403332A (en) 2021-09-17
CN113403332B CN113403332B (en) 2022-08-23

Family

ID=77683506

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110650939.2A Active CN113403332B (en) 2021-06-09 2021-06-09 Alpha-agarase gene and application of coding enzyme thereof

Country Status (1)

Country Link
CN (1) CN113403332B (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834257A (en) * 1995-11-06 1998-11-10 Japan Tobacco Inc. α-agarase and production process of oligosaccharides and monosaccharides
CN1347452A (en) * 1999-02-23 2002-05-01 宝酒造株式会社 Alpha-agarase and process for producing same
US20040132036A1 (en) * 2001-02-27 2004-07-08 Jun Tomono Agarase and gene thereof
CN109825466A (en) * 2019-04-10 2019-05-31 江南大学 A kind of method that straight chain maltopentaose generates enzyme secreting, expressing in bacillus subtilis
CN110438105A (en) * 2019-07-19 2019-11-12 自然资源部第三海洋研究所 A kind of α-agarase and the preparation method and application thereof
CN110527678A (en) * 2019-08-27 2019-12-03 中国海洋大学 A kind of novel alpha-agarase and its application

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834257A (en) * 1995-11-06 1998-11-10 Japan Tobacco Inc. α-agarase and production process of oligosaccharides and monosaccharides
CN1347452A (en) * 1999-02-23 2002-05-01 宝酒造株式会社 Alpha-agarase and process for producing same
US20040132036A1 (en) * 2001-02-27 2004-07-08 Jun Tomono Agarase and gene thereof
CN109825466A (en) * 2019-04-10 2019-05-31 江南大学 A kind of method that straight chain maltopentaose generates enzyme secreting, expressing in bacillus subtilis
CN110438105A (en) * 2019-07-19 2019-11-12 自然资源部第三海洋研究所 A kind of α-agarase and the preparation method and application thereof
CN110527678A (en) * 2019-08-27 2019-12-03 中国海洋大学 A kind of novel alpha-agarase and its application

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DULEEPA PATHIRAJA等: "A Novel Auxiliary Agarolytic Pathway Expands Metabolic Versatility in the Agar-Degrading Marine Bacterium Colwellia echini A3T", 《APPLIED AND ENVIRONMENTAL MICROBIOLOGY》 *
XU,Z.等: "GenBank: AYW35328.1", 《NCBI》 *

Also Published As

Publication number Publication date
CN113403332B (en) 2022-08-23

Similar Documents

Publication Publication Date Title
CN111712570B (en) Engineering strain for producing psicose and derivatives thereof, construction method and application thereof
CN106884025B (en) Method for directionally preparing alginate oligosaccharides by enzymatic hydrolysis
WO2022095591A1 (en) Compound enzyme and application thereof in preparation of l-ergothioneine
CN103468624B (en) Genetic engineering bacteria used for high efficient production of mycose
CN107460138A (en) A kind of recombinant yeast pichia pastoris for the glucose dehydrogenase that production FAD is relied on and its construction method and application
CN112725319B (en) Alginate lyase FaAly7 with polyG substrate specificity and application thereof
US20230272443A1 (en) N-Acetylglucosamine-Producing Bacterial Strain As Well As Method Of Construction And Use Thereof
CN113234699A (en) Alpha-1, 2-fucosyltransferase and application thereof
CN107227284B (en) Recombinant streptococcus zooepidemicus of fermented micromolecular hyaluronic acid
CN105039374A (en) Starch induction type recombinant bacillus subtilis as well as preparation method and application thereof
CN113528553B (en) Codon-optimized N-acetylglucosamine transferase gene and application thereof
CN105039371A (en) Trehalose synthase-trehalose hydrolase fusion enzyme, expression gene thereof and application
CN113337495B (en) Method for improving sialic acid yield and application
CN102925423B (en) Mutated cephalosporin C acylase
CN110144341B (en) Alginate lyase mutant
AU2021440288A1 (en) ENZYME COMPOSITION FOR PREPARING β-NICOTINAMIDE MONONUCLEOTIDE, AND APPLICATION THEREOF
CN111411066B (en) Double-way composite neuraminic acid-producing bacillus subtilis and construction method thereof
CN111607626A (en) Application of cyclodextrin enzyme in preparation of maltoheptaose
CN113403332B (en) Alpha-agarase gene and application of coding enzyme thereof
CN111394410A (en) High-catalytic-activity neuraminic acid synthase and application thereof
CN113005132B (en) D-psicose-3-epimerase gene and application method thereof
CN113493747A (en) Mutant strain of high-yield cyclodextrin glucosyltransferase and application thereof
WO2023169200A1 (en) Recombinant yeast and application thereof
CN111411065B (en) Recombinant bacterium for producing N-acetylneuraminic acid based on artificial double carbon sources
NL2030021B1 (en) L-ARABINOSE ISOMERASE (L-Al) DERIVED FROM LACTOCOCCUS LACTIS (L. LACTIS), AND USE THEREOF IN PREPARATION OF RARE SUGAR

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant